Home/Kaer Biotherapeutics/Donovan Yeates, PhD
DY

Donovan Yeates, PhD

CEO & Founder

Kaer Biotherapeutics

Kaer Biotherapeutics Pipeline

DrugIndicationPhase
AeroPulsR / SUPRAER PlatformAcute & Chronic Respiratory Disorders (e.g., in ICU, COPD, Asthma)Pre-clinical
Industrial Automation for Animal HealthMass Vaccination in LivestockDevelopment